Yi-Hsiang Huang

86PUBLICATIONS
212CO-AUTHORS
Major global burdens of diseasePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (86)

|Jul 21, 2026
An in-hospital referral program for hepatitis C virus elimination in patients with type 2 diabetes mellitus.

|Jul 04, 2026
Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection.

|Apr 20, 2026
Optimal treatment selection for hepatocellular carcinoma in the era of immunotherapy.

|Feb 12, 2026
Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma.

Pei-Chang Lee, Yi-Hsiang Huang, David James Pinato

|Jul 09, 2025
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.

Chun-Yu Wei, Ming-Shien Wen, Chih-Kuang Cheng

|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study.

Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li

Pageof 15

Frequent Collaborators

21 joint publications

Chien-Wei Su

19 joint publications

Teh-Ia Huo

8 joint publications

Ming-Chih Hou

8 joint publications

Cheng-Yuan Peng